Synonyms: Avelox® | BAY-12-8039 | BAY-128039 | BAY128039 | MFX | MOXIVIG® (opthalmic solution)
moxifloxacin is an approved drug (FDA (1999), UK (2009))
Compound class:
Synthetic organic
Comment: Moxifloxacin is a fourth generation fluoroquinolone antibacterial. Compared to earlier generation fluoroquinolones it has expanded activity against Gram-positive bacteria and some atypical pathogens.
|
|
References |
1. Gellert M, Mizuuchi K, O'Dea MH, Nash HA. (1976)
DNA gyrase: an enzyme that introduces superhelical turns into DNA. Proc Natl Acad Sci U S A, 73 (11): 3872-6. [PMID:186775] |
2. Lauderdale TL, Shiau YR, Lai JF, Chen HC, King CH. (2010)
Comparative in vitro activities of nemonoxacin (TG-873870), a novel nonfluorinated quinolone, and other quinolones against clinical isolates. Antimicrob Agents Chemother, 54 (3): 1338-42. [PMID:20065058] |